Sorry, but Notd.io is not available without javascript Bitter battle over ‘orphan drug’ program leaves patients’ pocketbooks at risk - notd.io

Read more about Bitter battle over ‘orphan drug’ program leaves patients’ pocketbooks at risk
Read more about Bitter battle over ‘orphan drug’ program leaves patients’ pocketbooks at risk
Bitter battle over ‘orphan drug’ program leaves patients’ pocketbooks at risk

A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her insurance to pay for it. But now, her Medicare insurance is shelling out about $40,000 for a one-month supply of the drug, and she fears she’ll be slammed with a $9,000 copayment.
Want to read more?

You can publish here, too - it's easy and free.